Clinical Trial Update: A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating durvalumab with R-CHOP or lenalidomide plus R-CHOP in previously untreated high-risk diffuse large B-cell lymphoma is completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Durvalumab (durvalumab)
• Lenalidomide (lenalidomide)
• R-CHOP

Snippet

Sponsor: Celgene | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 2 | Status: COMPLETED | Results posted: 2019-09-16